Virtual Agent for Lung Cancer

Overseen By Laura Alder, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Duke University

Disqualifiers: Vision, speech, auditory impairment, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

36 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to compare the use of a virtual agent vs. a human agent when onboarding oncology patients over the telephone to Remote Patient Monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. Both the virtual and human agents will be available by telephone to instruct the patient on how to use the RPM devices to measure weight, blood pressure, heart rate, temperature, and oxygen saturation. Patients will be randomized to either the virtual or human agent, have assessments of their medical and oncological history, overall well-being, body measurements, and vital signs, and will complete questionnaires about their experience.

Who Is on the Research Team?

Laura Alder, MD

Principal Investigator

Duke University

Are You a Good Fit for This Trial?

This trial is for adults over 18 with lung cancer who can consent to share health info, have an ECOG score of 0-2 indicating they are fully active or limited in physical activity but able to care for themselves, speak fluent English, and meet specific vital sign criteria. They must plan to return to Duke Cancer Center clinic for three consecutive days.

Inclusion Criteria

I am willing to sign a consent form and allow my health information to be shared.

I am 18 years old or older.

I have lung cancer.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Onboarding

Participants are onboarded to Remote Patient Monitoring devices using either a virtual or human agent

3 days

Remote onboarding via telephone

Follow-up

Participants complete questionnaires about their experience and usability of the onboarding process

1 week

What Are the Treatments Tested in This Trial?

Interventions

• Human Agent
• Virtual Agent

Trial Overview The study compares a virtual agent versus a human agent instructing patients on using Remote Patient Monitoring devices by phone. These devices track weight and vital signs like blood pressure and heart rate. Participants will be randomly assigned to one of the agents and complete questionnaires about their experience.

How Is the Trial Designed?

Group I: Virtual agent Experimental Treatment 1 Intervention

Group II: Human agent Active Control 1 Intervention

Who Is Running the Clinical Trial?

Duke University

Lead Sponsor

Trials

2,495

Recruited

5,912,000+